Faculty of Medicine researchers receive $15M from CIHR’s Project Grant program – UBC Faculty of Medicine

Posted: Published on September 23rd, 2020

This post was added by Alex Diaz-Granados

Twenty-two research projects led by researchers from the Faculty of Medicine and affiliated health authority research centres were awarded $15 million from the Canadian Institute of Health Research Project Grant Spring 2020 competition.

The Project Grant program supports researchers in building and conducting health-related research and knowledge translation projects, covering all areas of health.

In addition to the Project Grant Spring 2020 competition, one Faculty of Medicine project was awarded a priority announcement bridge grant of $100,000.

Pilot RCT for cognitive-behavioural & mindfulness-based online programs for female sexual dysfunction UBC Principal Investigator: Dr. Lori Brotto, department of obstetrics & gynaecology

Identification of HOXB13 inhibitors to treat castrate-resistant prostate cancer UBC Principal Investigators: Dr. Martin Gleave, department of urologic sciences, Nathan Lack, department of urologic sciences

Predicting and Evaluating Anal Cancer in HIV with novel biomarkers: The PEACH Study UBC Principal Investigators: Dr. Jonathan (Troy) Grennan, department of medicine

A randomized trial of doxycycline chemoprophylaxis for the prevention of sexually transmitted infections in gay, bisexual and other men who have sex with men (gbMSM) UBC Principal Investigators: Dr. Jonathan (Troy) Grennan, department of medicine, Mark Hull, department of medicine

Chronic diseases in mothers and risks of neuro-developmental disorders in offspring: an international comparison UBC Principal Investigator: Dr. K. S. Joseph, School of Population and Public Health

Novel endothelial engineering and localized immunosuppression approaches for the protection of organ transplants UBC Principal Investigators: Dr. Jayachandran Kizhakkedathu, department of pathology and laboratory medicine

Childhood Epigenetic Age Deviations and Developmental Differences (CEAD3) UBC Principal Investigator: Dr. Michael Kobor, department of medical genetics

Characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations. UBC Principal Investigator: Dr. Blair Leavitt, department of medical genetics

Improving clinical practice recommendations for late preterm antenatal corticosteroids: incorporating a decision support tool to tackle the uncertain balance of risks and benefits UBC Principal Investigator: Dr. Jessica Liauw, department of obstetrics & gynaecology

Enterovirus subversion of the autophagy pathway UBC Principal Investigator: Dr. Honglin Luo, department of pathology and laboratory medicine

Reducing unsafe prescribing of prescription opioid medications to opioid nave patients UBC Principal Investigators: Dr. Rita McCracken, department of family practice, Evan Wood, department of medicine

Maternal exposures during pregnancy as drivers of susceptibility to allergic asthma and Th2 inflammation. UBC Principal Investigator: Dr. Kelly McNagny, department of medical genetics

Self-Management for Amputee Rehabilitation using Technology (SMART) program: A peer supported mHealth approach for rehabilitation after lower limb amputation UBC Principal Investigators: Dr. William Miller, department of occupational science and occupational therapy, Maureen Ashe, department of family practice, William Mortenson, department of occupational science and occupational therapy, Michael Payne, medical microbiology

Evaluating tetrahydrocannabinol as an adjunct to opioid agonist therapy for individuals living with opioid use disorder: A Phase II, placebo-controlled, blinded, pilot study to assess safety and feasibility UBC Principal Investigator: Dr. Michael-John Milloy, department of medicine

Engaging and retaining marginalized populations in primary health care in the downtown east side of Vancouver UBC Principal Investigator: Dr. David Moore, department of medicine

Improved Assessment of Disease in Lymphoma Patients using Quantitative PET Imaging UBC Principal Investigator: Dr. Arman Rahmim, department of radiology

Delineating between pathophysiologic phenotypes of hypoxic ischemic brain injury after cardiac arrest UBC Principal Investigator: Dr. Mypinder Sekhon, department of medicine

Tissue resident and migratory group 2 innate lymphoid cells in health and disease UBC Principal Investigator: Dr. Fumio Takei, department of pathology & laboratory medicine

Neuro-cardiac predictors of treatment response to rTMS in depression: a mechanistic study using interleaved TMS-fMRI UBC Principal Investigator: Dr. Fidel Vila-Rodriguez, department of psychiatry

Low frequency repetitive transcranial magnetic stimulation (TMS) vs. intermittent Theta Burst Stimulation TMS effectiveness in depression and suicidal ideation: a randomized non-inferiority trial UBC Principal Investigator: Dr. Fidel Vila-Rodriguez, department of psychiatry

The role of PRDM16 in neuroendocrine prostate cancer development and aggressiveness UBC Principal Investigator: Dr. Yuzhuo Wang, department of urologic sciences

A prospective and longitudinal investigation of concussive and subconcussive mild traumatic brain injury mechanisms in ice hockey UBC Principal Investigators: Dr. Alexander Rauscher, department of pediatrics, Lyndia (Chun) Wu, Faculty of Applied Science, Paul van Donkelaar, Faculty of Health and Social Development

Understanding Human Primary Atopic Disorders (Priority Announcement:Skin Conditions) UBC Principal Investigators: Dr. Stuart Turvey, department of pediatrics, Catherine Biggs, department of pediatrics

More:
Faculty of Medicine researchers receive $15M from CIHR's Project Grant program - UBC Faculty of Medicine

Related Posts
This entry was posted in Brain Injury Treatment. Bookmark the permalink.

Comments are closed.